TWST Twist Bioscience Corp

Price (delayed)

$52.97

Market cap

$2.99B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.95

Enterprise value

$2.69B

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of ...

Highlights
TWST's gross profit is up by 45% year-on-year and by 18% since the previous quarter
TWST's revenue is up by 45% YoY and by 13% from the previous quarter
Twist Bioscience's equity has increased by 34% YoY but it has decreased by 4.9% QoQ
The net income has shrunk by 54% YoY and by 11% QoQ
TWST's EPS is down by 41% year-on-year and by 7% since the previous quarter

Key stats

What are the main financial stats of TWST
Market
Shares outstanding
56.36M
Market cap
$2.99B
Enterprise value
$2.69B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.63
Price to sales (P/S)
16.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.59
Earnings
Revenue
$184.21M
EBIT
-$218.21M
EBITDA
-$200.43M
Free cash flow
-$251.41M
Per share
EPS
-$3.95
Free cash flow per share
-$4.47
Book value per share
$14.59
Revenue per share
$3.27
TBVPS
$14.79
Balance sheet
Total assets
$979.66M
Total liabilities
$158.99M
Debt
$78.6M
Equity
$820.68M
Working capital
$531.43M
Liquidity
Debt to equity
0.1
Current ratio
6.73
Quick ratio
6.14
Net debt/EBITDA
1.49
Margins
EBITDA margin
-108.8%
Gross margin
40.2%
Net margin
-112.9%
Operating margin
-118.2%
Efficiency
Return on assets
-23.8%
Return on equity
-28.8%
Return on invested capital
-56.8%
Return on capital employed
-24.6%
Return on sales
-118.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TWST stock price

How has the Twist Bioscience stock price performed over time
Intraday
7.93%
1 week
0.38%
1 month
30.4%
1 year
-50.47%
YTD
-31.55%
QTD
51.52%

Financial performance

How have Twist Bioscience's revenue and profit performed over time
Revenue
$184.21M
Gross profit
$73.97M
Operating income
-$217.72M
Net income
-$207.99M
Gross margin
40.2%
Net margin
-112.9%
Twist Bioscience's operating income has plunged by 59% YoY and by 10% from the previous quarter
The net income has shrunk by 54% YoY and by 11% QoQ
TWST's gross profit is up by 45% year-on-year and by 18% since the previous quarter
TWST's revenue is up by 45% YoY and by 13% from the previous quarter

Growth

What is Twist Bioscience's growth rate over time

Valuation

What is Twist Bioscience stock price valuation
P/E
N/A
P/B
3.63
P/S
16.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
14.59
TWST's EPS is down by 41% year-on-year and by 7% since the previous quarter
Twist Bioscience's equity has increased by 34% YoY but it has decreased by 4.9% QoQ
TWST's P/B is 29% below its last 4 quarters average of 5.1
TWST's revenue is up by 45% YoY and by 13% from the previous quarter
TWST's P/S is 30% below its last 4 quarters average of 23.1

Efficiency

How efficient is Twist Bioscience business performance
Twist Bioscience's ROIC has decreased by 18% YoY but it has increased by 7% from the previous quarter
The return on equity has declined by 17% year-on-year and by 2.9% since the previous quarter
The ROA has decreased by 10% YoY and by 2.6% from the previous quarter
TWST's return on sales is down by 10% year-on-year but it is up by 3.3% since the previous quarter

Dividends

What is TWST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TWST.

Financial health

How did Twist Bioscience financials performed over time
TWST's quick ratio is down by 39% year-on-year and by 15% since the previous quarter
Twist Bioscience's total liabilities has increased by 38% YoY
Twist Bioscience's debt is 90% less than its equity
Twist Bioscience's equity has increased by 34% YoY but it has decreased by 4.9% QoQ
Twist Bioscience's debt has increased by 23% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.